Photodynamic therapy of cancer: An update
Top Cited Papers
Open Access
- 26 May 2011
- journal article
- research article
- Published by Wiley in CA: A Cancer Journal for Clinicians
- Vol. 61 (4), 250-281
- https://doi.org/10.3322/caac.20114
Abstract
Photodynamic therapy (PDT) is a clinically approved, minimally invasive therapeutic procedure that can exert a selective cytotoxic activity toward malignant cells. The procedure involves administration of a photosensitizing agent followed by irradiation at a wavelength corresponding to an absorbance band of the sensitizer. In the presence of oxygen, a series of events lead to direct tumor cell death, damage to the microvasculature, and induction of a local inflammatory reaction. Clinical studies revealed that PDT can be curative, particularly in early stage tumors. It can prolong survival in patients with inoperable cancers and significantly improve quality of life. Minimal normal tissue toxicity, negligible systemic effects, greatly reduced long‐term morbidity, lack of intrinsic or acquired resistance mechanisms, and excellent cosmetic as well as organ function‐sparing effects of this treatment make it a valuable therapeutic option for combination treatments. With a number of recent technological improvements, PDT has the potential to become integrated into the mainstream of cancer treatment. CA Cancer J Clin 2011. © 2011 American Cancer Society, Inc.Keywords
This publication has 282 references indexed in Scilit:
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion QuestionJNCI Journal of the National Cancer Institute, 2009
- Disruption of the blood–brain barrier following ALA‐mediated photodynamic therapyLasers in Surgery and Medicine, 2008
- Photodynamic therapy-generated vaccines: relevance of tumour cell death expressionBritish Journal of Cancer, 2007
- Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activationProceedings of the National Academy of Sciences of the United States of America, 2007
- CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cellsBritish Journal of Cancer, 2007
- Organically Modified Silica Nanoparticles Co-encapsulating Photosensitizing Drug and Aggregation-Enhanced Two-Photon Absorbing Fluorescent Dye Aggregates for Two-Photon Photodynamic TherapyJournal of the American Chemical Society, 2007
- Surgical and Palliative Management and Outcome in 184 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2006
- Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cellsBritish Journal of Cancer, 2006
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell deathNature, 2005